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Summary
We consider two recent suggestions for how to perform an empirically mo-
tivated Monte Carlo study to help select a treatment effect estimator under
unconfoundedness. We show theoretically that neither is likely to be infor-
mative except under restrictive conditions that are unlikely to be satisfied in
many contexts. To test empirical relevance, we also apply the approaches to
a real-world setting where estimator performance is known. Both approaches
are worse than random at selecting estimators which minimise absolute bias.
They are better when selecting estimators that minimise mean squared error.
However, using a simple bootstrap is at least as good and often better. For now
researchers would be best advised to use a range of estimators and compare
estimates for robustness.
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1 Introduction
A large literature focuses on estimating average treatment effects under unconfounded-
ness (see, e.g., Blundell and Costa Dias 2009, Imbens and Wooldridge 2009, Abadie and
Cattaneo 2018).1 Many estimators are available to researchers in this context, and many
of these estimators have similar asymptotic properties. This can make it difficult to select
which estimator to use. Monte Carlo studies are a useful tool for examining the small-
sample properties of these estimation methods, which can guide estimator choice.2 Early
contributions, such as Fro¨lich (2004), demonstrate estimator performance in stylised data
generating processes (DGPs) which do not resemble any empirical settings. This reliance
on unrealistic DGPs is criticised by Huber et al. (2013) and Busso et al. (2014). Both rec-
ommend that Monte Carlo studies should intend to replicate actual datasets of interest,
although they suggest different procedures for doing this. Huber et al. (2013) describe this
approach to examining the small-sample properties of estimators as an ‘empirical Monte
Carlo study’ (EMCS). An important question is whether either type of EMCS can help
applied researchers in choosing what estimator(s) to prefer in a given context. Busso et al.
(2014) indicate this might be possible, noting that their results ‘suggest the wisdom of
conducting a small-scale simulation study tailored to the features of the data at hand’.
Similarly, Huber et al. (2013) suggest that ‘the advantage [of an EMCS] is that it is valid in
at least one relevant environment’, i.e. that it is informative at least about the performance
of estimators in the dataset on which it was conducted.
In this paper we evaluate the premise that EMCS can be informative about the per-
formance of estimators in the particular data which are the basis for the EMCS. We first
show theoretically that these approaches are expected to be informative only under very
restrictive conditions. These conditions are unlikely to hold in many practical examples
faced by a researcher. We then test EMCS performance in a real-world case where we
know the actual behaviour of estimators. We find that in terms of selecting estimators
on absolute bias they are often worse than choosing randomly. On mean squared error
(MSE) they perform better than random, but no better than selecting an estimator based
on simple bootstrap estimates of MSEs. Their performance in absolute terms may also
still be poor.
1The unconfoundedness assumption may also be referred to as exogeneity, ignorability, or selection on
observables.
2See, for example, Fro¨lich (2004), Lunceford and Davidian (2004), Zhao (2004, 2008), Busso et al. (2009),
Millimet and Tchernis (2009), Austin (2010), Abadie and Imbens (2011), Khwaja et al. (2011), Diamond and
Sekhon (2013), Huber et al. (2013), Busso et al. (2014), Fro¨lich et al. (2017), and Bodory et al. (2018), all study-
ing the finite-sample performance of estimators of average treatment effects under unconfoundedness.
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The first type of EMCS we consider is the placebo EMCS (Huber et al., 2013).3 This
proposes a way to assign ‘realistic placebo treatments among the non-treated’, using in-
formation about the predictors of treatment status in the original data. It then tests how
well estimators can recover the zero effect of the placebo treatment. The performance of
estimators in this exercise is hypothesised to be informative about their performance in
the original data.
The second type we describe as the structured EMCS. An exercise of this type is un-
dertaken by Busso et al. (2014).4 Here a parameterised approximation of the original data
generating process is created, using functional form assumptions about the distributions
of observed covariates. Parameters of their marginal (or conditional) distributions are
estimated from the original data. Samples can be drawn from this approximate DGP, to
which the estimators can then be applied. Since the treatment effect in this DGP can be
calculated directly from knowledge of the parameters, performance of the estimators in
these samples can be measured. The performance of estimators in this exercise is also
hypothesised to be informative about their performance in the original data.
To examine whether or not EMCS can correctly choose a best performing estimator,
for various definitions of performance, we first focus on a simple example with two esti-
mators that have Gaussian sampling distributions. We show analytically that both these
approaches will only be guaranteed to correctly select the preferred estimator if they can
correctly reproduce both the biases and the ordering of the variances of estimators. These
are restrictive conditions that we show can easily fail in practical applications, such as
when the EMCS procedures fail to recover heteroskedastic errors or misspecify the re-
gression equations or propensity scores. In two sets of simulations based on a stylised
DGP, both approaches select the better estimator less than 3% of the time, much worse
than 50% achievable by selecting randomly.
To study the extent of the problem in a real-world circumstance, we apply both meth-
ods to the National SupportedWork (NSW) Demonstration data onmen, previously anal-
ysed by LaLonde (1986), Heckman and Hotz (1989), Dehejia and Wahba (1999, 2002),
Smith and Todd (2001, 2005), and many others. In these data participation in a job train-
ing programme was randomly assigned, so the treatment effect of the programme can
be estimated by comparing sample means. LaLonde (1986) used these data to test the
performance of estimators at reproducing this treatment effect when an artificial compar-
ison group (rather than the experimental controls) was used. We instead use the data to
3It is also applied by Lechner and Wunsch (2013), Huber et al. (2016), Fro¨lich et al. (2017), Lechner and
Strittmatter (2017), and Bodory et al. (2018). A related approach is proposed by Schuler et al. (2017).
4A similar approach is also used by Abadie and Imbens (2011), Lee (2013), and Dı´az et al. (2015).
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test how well the two EMCS procedures can inform us about the performance of the es-
timators: Can EMCS tell us which estimator to use? On average how much worse than
the optimal estimator is the one chosen by EMCS? How well can EMCS reproduce the
ranking of performance across all estimators?
Applying the two EMCS procedures we find three main results. First, in terms of ab-
solute bias, the EMCS procedures are no better, and often noticeably worse, than selecting
an estimator at random. In two out of three cases we study, the rankings produced are
negatively correlated with the true ranking. In one case the preferred estimator selected
by EMCS is on average 30–37 times worse than the actual best estimator.
Second, EMCS does better at reproducing the performance of estimators in terms of
MSE. This is because the MSEs of the estimators are mostly driven by their variances,
and EMCS appears more effective at capturing variances. The rankings of estimators are
consistently positively correlated with the true rankings, although the estimator preferred
by EMCS has an MSE up to twice as high as the best estimator.
Third, given the variance result, we also compare EMCS procedures to choosing esti-
mators based on performance criteria estimated from a simple nonparametric bootstrap.
We find that the bootstrap is as good, and often much better, than either of the EMCS
procedures. Hence even when the procedures are somewhat informative, they are not
superior to a procedure that relies on fewer design choices.
These results are unfortunate, but nevertheless important. They caution against treat-
ing either of these approaches as general solutions to the problem of estimator choice.
There remains no silver bullet that can assist empirical researchers with the ‘right’ or ‘best’
estimator for a particular context. In the absence of a clear choice driven by research de-
sign, the best advice at this stage is likely to be implementing a number of estimators, and
then considering the range of estimates provided, as Busso et al. (2014) also suggest.
Our results also have implications for researchers studying the small-sample proper-
ties of treatment effect estimators (see footnote 2). It has been argued that ‘it is preferable
to study DGPs that are empirically relevant’ (Busso et al., 2014). Our theoretical and em-
pirical results suggest there is little support for this claim. We show theoretically that
misspecification in the construction of the DGP can lead the ranking of estimators to be
incorrect for the original dataset. In our empirical example, we see that EMCS is not better
than using a bootstrap (and sometimes not better than random) to predict performance in
the data on which the EMCS was performed. There seems to be little reason to then think
it is particularly informative about performance in other unrelated real datasets, i.e. that
testing small-sample properties of estimators in ‘real data’ is necessarily better than in
completely artificial data. A more fruitful path might be to test sensitivity of estimator
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performance to parameters of the simulation, such as sample size and the degree of het-
eroskedasticity. This approach is also taken by Huber et al. (2013), and might be more
helpful in understanding what characteristics of samples most affect the performance of
particular estimators.
2 EMCS Designs
We first describe the two main approaches to conducting an EMCS, namely the placebo
design of Huber et al. (2013) and the structured design of Busso et al. (2014). In either
EMCS design, one simulates many ‘empirical Monte Carlo’ replication samples from a
known data generating process. By implementing the estimators on the simulated repli-
cations, one obtains estimates of the sampling distributions and performance criteria
(e.g., MSEs) of the estimators, according to which one ranks the candidate estimators.
Note that the researcher needs to make a choice of what criteria to use to rank estimators.
2.1 The Placebo Design
The idea of the placebo design is to assign placebo treatments to some control observa-
tions, so that by construction the treatment effect is zero, and to then attempt to recover
this effect.5 In particular, covariates and outcomes (Xi ,Yi) are first drawn jointly by sam-
pling (with replacement) from the empirical distribution of control observations. Using
the original dataset, the propensity score is estimated (e.g., using a logit model). The es-
timated parameters of this model φˆ are then used to assign placebo treatments to the
generated sample in the following way:
Di = 1[Si > 0], (1)
Si = π + λXiφˆ + ǫi, (2)
where ǫi is an iid error, and both π and λ are additional parameters to be selected. While
π shifts the proportion of observations that are treated, λ controls the extent of selection:
with λ = 1 selection on observables takes the same form in the Monte Carlo samples as
in the original dataset.
5A similar approach is developed by Bertrand et al. (2004) who study inference in difference-in-
differences methods using simulations with randomly generated ‘placebo laws’ in state-level data, i.e. pol-
icy changeswhich never actually happened. For follow-up studies, seeHansen (2007), Cameron et al. (2008),
and Brewer et al. (2018).
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2.2 The Structured Design
The idea of the structured design is instead to create a parameterised approximation to
the original (unknown) data generating process, and then draw samples from the approx-
imated process. To begin, a fixed number of treated and control observations are created,
to match the number of each in the original dataset. Covariates and outcome variables are
then drawn from parameterised distributions where the parameters are estimated from
the original dataset. For example, the variable black might come from a Bernoulli with
mean estimated from the data, and the variable earnings from a log-normal distribution
with mean and variance estimated from the data. The parameters of these distributions
are typically estimated conditional on treatment status. Parameters of some distributions
might also be conditional on the value of other variables; e.g., earnings might be condi-
tional on race as well as treatment status. More conditioning will improve the match of
the joint distribution of simulated data to the joint distribution of the original data, but
will increase the number of parameters that need to be estimated.
3 Theory
To understand the conditions under which an EMCS might be informative about the pre-
ferred estimator in some particular dataset, we first construct a simple example. Here
we have only two estimators, with a straightforward and restricted joint sampling dis-
tribution (bivariate Gaussian). This bivariate Gaussian setting mimics an ideal situation
in which the finite sample distribution of the estimators is well approximated by their
asymptotic distribution. We show that even in such an ideal, large sample situation,
EMCS can fail to select the best estimator if the bias in any one of the estimators or the
ranking of variances is not correctly replicated in the simulated samples. We provide
simple common cases for treatment effect estimation in which failure to capture the biases
and heteroskedasticity contaminates EMCS, and provide results from a simple simulation
illustrating this. We then extend the example to the case of more than two estimators.
3.1 Simple Example: Two Estimator Case
Suppose the researcher wants to rank two estimators θˆ1 and θˆ2 according to their statistical
performances under repeated sampling. These estimators are estimating the same object
of interest θ ∈ R, but their constructions are different. For simplicity of the illustration,
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assume that the joint sampling distribution of the two estimators is bivariate Gaussian:(
θˆ1
θˆ2
)
∼ N
((
θ1
θ2
)
,Σn
)
, (3)
where Σn = n−1Σ, Σ =
(
σ21 σ12
σ12 σ
2
2
)
, and n is the sample size. Here, our implicit assump-
tion is that the estimators (θˆ1, θˆ2) converge to (θ1, θ2) at
√
n-rate. Let θ0 be the true value
of the parameter of interest. We allow θˆ1 and/or θˆ2 to be biased so that θ1 and/or θ2 can
differ from θ0.
We rank these estimators according to their statistical performances. Given that we
often assess the performance of an estimator by its mean squared error (MSE) or mean
absolute error (MAE), we may, for instance, rank the estimators according to their MSEs
or MAEs.6 Given the Gaussian assumption, the MSE of each estimator, j = 1, 2, is
MSE(θˆj) = (θj − θ0)2 + n−1σ2j .
We denote by j0 ∈ {1, 2} the index of the strictly preferred estimator, assuming it
exists. Ranking the estimators is difficult in practice since we do not know the mean and
variances of the estimators as well as the true value of θ. Proposals of the EMCS literature
aim to infer a best performing estimator j0 by estimating the sampling distribution of
θˆ1 and θˆ2 via some Monte Carlo studies. For simplicity, we assume that the estimators
simulated in EMCS also follow bivariate Gaussian,(
θˆ∗1
θˆ∗2
)
∼ N
((
θ˜1
θ˜2
)
, Σ˜n
)
, (4)
where Σ˜n = a−1n Σ˜, Σ˜ =
(
σ˜21 σ˜12
σ˜12 σ˜
2
2
)
, and an is the size of a simulated sample that may dif-
fer from the size of the original sample n. The underlying parameters in EMCS, (θ˜1, θ˜2, Σ˜),
generally depend on the original sample, but we assume for simplicity that the depen-
dence is negligible and they can be treated as constants. EMCS computes θˆ∗1 and θˆ
∗
2 re-
peatedly using simulated samples of size an drawn from a data generating process with
6MSE and MAE criteria do not take into account the dependence of the estimators. One way to rank
the estimators that takes into account their dependence is based on the probability of being closer to the truth,
Pr(|eˆ1| ≤ |eˆ2|), where eˆ1 = θˆ1 − θ0 and eˆ2 = θˆ2 − θ0 are the estimation errors of the two estimators. That is,
θˆ1 is preferred to θˆ2 if Pr (|eˆ1| ≤ |eˆ2|) > 1/2 and θˆ2 is preferred to θˆ1 if Pr (|eˆ1| ≤ |eˆ2|) < 1/2. Considering
this criterion instead of MSE does not affect the main results in our simple example.
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the parameter value set at known value θ˜0. For instance, the placebo EMCS approach of
Huber et al. (2013) sets θ˜0 = 0 and an ≤ n0, the size of the control group in the original
data. The approach of structured EMCS sets θ˜0 at an estimate of θ0 constructed from the
original sample. In implementing EMCS, we do not have to know the mean and variance
parameters of (θˆ∗1 , θˆ
∗
2), and they can be estimated with arbitrary accuracy based on the
simulated estimators. EMCS accordingly obtains the MSE of each estimator, j = 1, 2, by
M̂SE(θˆj) = (θ˜j − θ˜0)2 + a−1n σ˜2j .
We denote by jˆ0 the index for a best performing estimator estimated from EMCS,
jˆ0 ≡ argminj M̂SE(θˆj). To assess the validity of EMCS, we define a criterion of EMCS-
validity by the probability that jˆ0 coincides with j0, Pr( jˆ0 = j0), where the probability is
evaluated under repeated sampling of the original samples. In the examples to follow,
we investigate how this criterion of EMCS-validity becomes one or zero depending on
the parameter values in the bivariate Gaussian distributions of (3) and (4). We assume
away the dependence of the parameters in (4) on the original sample for simplicity of
illustration. In such a case the MSE estimates in EMCS and resulting selection of a best
estimator jˆ0 are nonrandom when the number of Monte Carlo iterations is large enough.
The criterion of EMCS-validity in this case is either 1 or 0.
We can also consider the average regret type criterion such asE(MSE(θˆ jˆ0 )−MSE(θˆj0 )) ≥
0 to quantify EMCS-validity. Here, the expectation concerns the sampling distribution of
EMCS’s selection of an optimal estimator jˆ0. This average regret criterion can quantify
severity of a wrong choice of the estimators in terms of how much MSE is on average
sacrificed relative to the true best-performing estimator.
3.1.1 Scenario 1
Denote the biases in (θˆ1, θˆ2)
′ by b = (b1, b2)′ = (θ1− θ0, θ2− θ0)′ and the biases in (θˆ∗1 , θˆ∗2)′
by b˜ = (b˜1, b˜2)
′ = (θ˜1 − θ˜0, θ˜2 − θ˜0)′. We start with a scenario in which (θˆ1, θˆ2) are un-
biased and the distribution of (θˆ∗1 , θˆ
∗
2) well replicates the distribution of (θˆ1, θˆ2) in the
following sense:
b = b˜ = 0, Σ = Σ˜. (5)
Here, the biases and the sample-size-adjusted variances of the estimators simulated in
EMCS coincide with those of the estimators in the original data generating process. Note
that the true parameter value assumed in EMCS, θ˜0, does not have to agree with the true
parameter value in the original sampling process, θ0.
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In the current scenario, the ranking of the true MSEs clearly coincides with the rank-
ing of the MSE estimates in EMCS, implying Pr( jˆ0 = j0) = 1. This is a benchmark case in
which EMCS works. The next two scenarios show that once we depart from the assump-
tions in (5), EMCS can be no longer valid.
3.1.2 Scenario 2
Assume that the estimators are free from biases both in the original data generating pro-
cess and EMCS, b = b˜ = 0, but EMCS fails to replicate the normalised covariance matrix
of the estimators, Σ 6= Σ˜. In this case, the MSE estimates in EMCS correctly rank the true
MSEs of the estimators (assuming σ21 6= σ22 ) if and only if the ordering of the variances
of the two estimators agrees between the original sampling process and the simulated
sampling process, i.e. (σ21 − σ22 )(σ˜21 − σ˜22 ) > 0. Otherwise, EMCS reverses the ranking of
the estimators and incorrectly selects a suboptimal estimator as optimal, Pr( jˆ0 = j0) = 0.
Hence, evenwhen EMCSwell replicates the biases of the estimators, it can fail to select
a best performing estimator due to an incorrect variance ordering.
3.1.3 Scenario 3
In the third scenario, we assume that EMCS correctly replicates the variance ordering
of the estimators, i.e. (σ21 − σ22 )(σ˜21 − σ˜22 ) > 0, but fails to replicate the biases, (b1, b2) 6=
(b˜1, b˜2). To be specific, we set (b˜1, b˜2) = (0, 0), but (b1, b2) = (0, b2), b2 6= 0. This can cor-
respond to a situation that the estimator 1 is correctly specified and has no bias, whereas
estimator 2 is misspecified and is subject to bias in the original data generating process.
EMCS, however, fails to capture the misspecification bias in estimator 2.
Suppose σ21 > σ
2
2 holds. The true MSEs are MSE(θˆ1) = n
−1σ21 and MSE(θˆ2) = b
2
2 +
n−1σ22 , while the MSE estimates in EMCS are M̂SE(θˆ1) = a−1n σ˜21 and M̂SE(θˆ2) = a
−1
n σ˜
2
2 .
Since we assumed that EMCS correctly replicates the variance of the estimators, EMCS
selects j = 2 as a best estimator. This selection of the estimator is indeed misleading if b2
is far from zero, since if |b2| >
√
σ21−σ22
n , θˆ1 outperforms θˆ2 in terms of MSE.
This scenario highlights that EMCS-based selection of the estimator can fail if any one
of the estimators is misspecified and the simulation design in EMCS does not replicate
the misspecification bias.
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3.2 Are Scenarios 2 and 3 Relevant in Treatment Effect Estimation?
We next provide simple but empirically relevant examples where we focus on the estima-
tion of treatment effects, and show that both types of EMCSmay yield misleading choices
of the estimators for the reasons illustrated in Scenarios 2 and 3 above.
Data are given by a random sample of {(Yi ,Di,Xi) : i = 1, . . . , n}, where Yi ∈ R is unit
i’s observed post-treatment outcome, Di ∈ {0, 1} is her treatment status, and Xi ∈ Rdx is a
vector of her pre-treatment characteristics whose support is assumed to be bounded. We
denote unit i’s potential outcomes by (Yi(1),Yi(0)). We assume the unconfoundedness
assumption, (Y(1),Y(0)) ⊥ D|X, throughout. The propensity score is denoted by e(x) =
Pr(D = 1|X = x).
3.2.1 An Example for Scenario 2
To keep our example as simple as possible, consider the following data generating pro-
cesses:
E(Y(1)|X = x) = β0 + β1 + x′β2, (6)
E(Y(0)|X = x) = β0 + x′β2,
Var(Y(1)|X = x) = cσ2ǫ , Var(Y(0)|X = x) = σ2ǫ , c > 0,
e(x) = γ0 + x
′γ1.
The specified mean equations for both potential outcomes imply that the conditional av-
erage treatment effects are homogeneous over observed characteristics and equal to β1.
The potential outcomes are heteroskedastic if c 6= 1. We assume a linear probability for
the propensity score in order to simplify analytical comparisons of the variances of the
estimators we introduce below.
Suppose that the parameter of interest is the population average treatment effect for
the treated (ATT), θ0 = E(Y(1) − Y(0)|D = 1). Since specification (6) implies homoge-
neous conditional average treatment effects, E(Y(1) − Y(0)|X = x) = β1, the true value
of ATT is θ0 = β1.
We consider two different estimators to estimate the population ATT. The first estima-
tor θˆ1 is a semiparametric estimator for ATT, which is consistent without assuming func-
tional forms for the outcome and propensity score equations, and asymptotically attains
the semiparametric efficiency bound (SEB) of ATT derived by Hahn (1998). Estimators
that attain this property include the inverse probability weighting (IPW) estimator with
nonparametrically estimated propensity scores (Hirano et al., 2003), doubly robust esti-
10
mators of Hahn (1998), covariate or propensity score matching estimators with a single
covariate (Abadie and Imbens, 2006, 2016), and covariate balancing estimators of Chen
et al. (2008) and Graham et al. (2012, 2016). We can set any one of these estimators as our
first estimator without affecting the analysis below.
We specify the second estimator θˆ2 as the ordinary least squares estimator of β1 in the
following regression equation:
Yi = β0 + β1Di + X
′
iβ2 + ǫi, E(ǫi|Di,Xi) = 0. (7)
In other words, θˆ2 = βˆ1,OLS. The specification of (6) implies that θˆ2 is unbiased and
consistent for the population ATT, θ0. We consider a situation in which the finite sample
distribution of (θˆ1, θˆ2) is well approximated by its large sample normal approximation,
i.e. (
θˆ1
θˆ2
)
∼ N
((
θ0
θ0
)
,
1
n
(
σ21 σ12
σ12 σ
2
2
))
,
where σ21 is the asymptotic variance of
√
n(θˆ1 − θ0) given by SEB for ATT without the
knowledge of propensity scores, and σ22 is the asymptotic variance of
√
n(θˆ2 − θ0). Under
the current specification, they are obtained as
σ21 =
σ2ǫ
Pr(D = 1)
[
c+ E
(
e(X)
1− e(X) |D = 1
)]
, (8)
σ22 =
σ2ǫ
Pr(D = 1)
[
c · E((1− e(X))
2 |D = 1)
[E(1− e(X)|D = 1)]2 +
E(e(X)(1 − e(X))|D = 1)
[E(1− e(X)|D = 1)]2
]
. (9)
See Appendix A for their derivations.
When Y(1) and Y(0) share the variance (c = 1), it can be shown that the OLS estima-
tor is more efficient than the semiparametric estimator, σ22 < σ
2
1 , due to exploitation of
the correct functional form of the regression equation. In contrast, if the variance of the
treated outcome is higher than the variance of the control outcome (c > 1), the simple
OLS estimator that does not take into account the heteroskedastic errors can become less
efficient than the semiparametric estimator. Specifically, we show in Appendix A that
σ22 > σ
2
1 iff c >
∆1
∆2
+ 1, where (10)
∆1 = E
[
1
1− e(X) |D = 1
]
− 1
E(1− e(X)|D = 1) ≥ 0,
∆2 =
E((1− e(X))2 |D = 1)
[E(1− e(X)|D = 1)]2 − 1 ≥ 0.
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Hence, if the degree of heteroskedasticity satisfies the condition in (10), the semiparamet-
ric estimator θˆ1 is strictly preferred to the OLS estimator θˆ2.
Given that cmeets (10), consider applying the placebo EMCS proposed in Huber et al.
(2013). We assume that the two estimators are centred at zero and their simulated distri-
butions can be well approximated by bivariate Gaussian,(
θˆ∗1
θˆ∗2
)
∼ N
((
0
0
)
,
1
n0
(
σ˜21 σ˜12
σ˜12 σ˜
2
2
))
,
where n0 is the sample size of control group in the original sample. Suppose also that the
propensity scores used to generate the placebo treatment coincide with the true propen-
sity scores in the original data. Since the placebo treated group is generated from the
original control group, it fails to replicate the variance of the treatment outcomes in the
original data. As a result, the variances of
√
n0 θˆ
∗
1 and
√
n0θˆ
∗
2 are given by the homoskedas-
tic version (c = 1) of (8) and (9),
σ˜21 =
σ2ǫ
P˜r(D = 1)
E˜
[
1
1− e(X) |D = 1
]
≥ σ˜22 =
σ2ǫ
P˜r(D = 1)
· 1
E˜(1− e(X)|D = 1) , (11)
where P˜r and E˜ are the probability and expectation with respect to the sampling distribu-
tion specified in the placebo EMCS. This inequality is strict if e(X)|D = 1 is nondegener-
ate. EMCS therefore incorrectly selects the OLS estimator θˆ2 as a preferred estimator.
The underlying mechanism for why EMCS goes wrong is in line with Scenario 2 in
the previous subsection. Even in a rather ideal situation where EMCS well replicates
the unbiasedness of the estimators, artificially creating a placebo treated group from the
control group in the original sample distorts the variance ordering among the estimators.
Exactly the same reasoning can also invalidate structured EMCS designs if the esti-
mated data generating process from which the data are to be simulated ignores or fails to
replicate the underlying heteroskedasticity of the potential outcome distributions.
This problem can be seen in a simple simulation study. We draw 1,000 samples from
a data generating process of the form given by equation (6) with 1,000 observations per
sample.7 For each sample we run 1,000 replications of the placebo and structured EMCS
procedures, considering IPW and OLS as our two estimators. This gives us ‘the true MSE’
for each estimator (based on the original samples) as well as 1,000 estimates of the MSE
for each combination of an estimator and an EMCS design. Looking at a simple count
7See Advani et al. (2019) for details: Appendix D for our procedure and parameter values; Appendix E
for simulation results.
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of how many times each procedure selects the right estimator, we see that the placebo
approach selects the superior estimator only 19 times (1.9% of the time) and the structured
approach is little better at 30 times (3.0%). This compares with 97.6% and 100% for the
placebo and structured procedures, respectively, when there is no heteroskedasticity. Of
course this is a single example, and in a very stylised context; in Section 4 we will see that
the performance of these methods is also poor in a ‘real-world’ example.
3.2.2 An Example for Scenario 3
We shift our focus to Scenario 3. We now introduce a bias in one of the estimators in the
original data generating process. For this purpose, we maintain the two estimators as in
the previous example, but alter the potential outcome equations from (6) with
E(Y(1)|X = x) = β0 + β1 + x′βt, (12)
E(Y(0)|X = x) = β0 + x′βc,
with distinct slopes, βt 6= βc. This causes the regression specification of (7) to be misspec-
ified so that θˆ2 is no longer consistent for the population ATT, plimn→∞θˆ2 = θ2 6= θ0 =
β1 + E(X
′|D = 1)(βt − βc). See, e.g., Słoczyn´ski (2018) for analytical characterizations
of the bias. On the other hand, the semiparametric estimator θˆ1 remains consistent and
semiparametrically efficient (asymptotically attains SEB). Hence, assuming that the finite
sample distribution of (θˆ1, θˆ2) is well approximated by its asymptotic normal approxima-
tion, we have (
θˆ1
θˆ2
)
∼ N
((
θ0
θ0 + b2
)
,
1
n
Σ
)
.
As we argued in Scenario 3 above, the bias in θˆ2 makes θˆ2 inferior to unbiased estimator
θˆ1 even when σ
2
2 < σ
2
1 if b2 or the sample size is sufficiently large.
In the placebo EMCS procedure of Huber et al. (2013), the fact that the placebo treated
group is generated from the original control group removes the misspecification issue
of the OLS estimator caused by the non-parallel potential outcome equations. Hence,
θˆ∗2 behaves as a correctly specified OLS estimator with homoskedastic errors, and the
simulated distribution of θˆ∗2 fails to replicate the bias in θˆ2. Since the variance ordering in
EMCS obtained in (11) is preserved in the current example, EMCS erroneously concludes
that the OLS estimator θˆ2 dominates the semiparametric estimator θˆ1.
In case of structured EMCS procedures, if the data generating process from which
Monte Carlo samples are drawn is estimated undermisspecification, the structured EMCS
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misleads the estimator selection for exactly the same reason. For example, if one were to
construct the Monte Carlo data generating process using linear regressions additive in Di,
structured EMCS will then wrongly conclude that the OLS estimator θˆ2 outperforms the
semiparametric estimator θˆ1.
Againwe perform a simple simulation, analogous to the previous subsection butmod-
ifying the potential outcome equations as given by equation (12). We perform 1,000 repli-
cations of each EMCS procedure using the same estimators, and then compare in how
many cases the EMCS correctly selects the estimator with the lower MSE. Again the per-
formance of EMCS is rather poor: placebo EMCS correctly selects IPW 2.3% of the time,
and structured EMCS is correct only .2% of the time. See Advani et al. (2019) for further
details.
3.3 More Than Two Estimators
Applications of EMCS often consider comparing more than two estimators. Fragility of
EMCS-based estimator selection highlighted in the two estimator examples above natu-
rally carries over to settings with more than two estimators, since ranking over multiple
estimators consists of transitive pairwise rankings of any two candidate estimators.
The Monte Carlo exercises and the empirical application below consider a setting
with seven estimators in the context of program evaluation with observational data. Let
(θˆ1, . . . , θˆJ) be the pool of J candidate estimators, and let the purpose of EMCS be to obtain
a complete ordering among these J estimators according to the MSE criteria.
The EMCS-validity criteria introduced above, Pr( jˆ0 = j0) andE(MSE(θˆ jˆ0 )−MSE(θˆj0)),
can be straightforwardly extended to the case with several estimators. In addition, to
measure similarity or dissimilarity between the true ranking and estimated rankings in
EMCS, it can be of interest to look at the distribution of the Kendall’s tau,
τˆ =
2
J(J − 1) ∑
i<j
1{(ρ(i)− ρ(j))(ρˆ(i)− ρˆ(j)) > 0}
where ρ(j) and ρˆ(j), j ∈ {1, . . . , J}, are the ranks of estimator j with respect to the true
MSE and estimated MSE in EMCS, respectively. Noting τˆ ∈ [−1, 1] has a distribution
under repeated sampling, its mean or other location parameters can summarise how well
EMCS can assess the relative performances among the candidate estimators.
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4 Application
To demonstrate the empirical relevance of the theoretical results discussed above, and
consider the extent to which they might be a problem in practice, we provide an applica-
tion of EMCS procedures to a real-world dataset. In these data we have an experimental
estimate of the treatment effect. By (initially) treating the experimental estimate as the
true treatment effect, the aim is to show whether (or not) EMCS procedures can accu-
rately recover the ranking of estimators that we see from the experiment. We first discuss
the data used, then our approach, next the estimators, and finally the details of how the
EMCS procedures were conducted.
4.1 Data and Context
We focus on the data for men from LaLonde (1986), used also by Heckman and Hotz
(1989), Dehejia and Wahba (1999, 2002), and Smith and Todd (2001, 2005).8 A subset of
these data comes from the National Supported Work (NSW) Demonstration, which was a
work experience programme that operated in the mid-1970s at 15 locations in the United
States (for a detailed description of the programme see Smith and Todd, 2005). This pro-
gramme served several groups of disadvantaged workers, such as women with depen-
dent children receiving welfare, former drug addicts, ex-convicts, and school drop-outs.
Unlike many social programmes, the NSW implemented random assignment among el-
igible participants. This random selection allowed for straightforward evaluation of the
programme via a comparison of mean outcomes in the treatment and control groups.
In an influential paper, LaLonde (1986) uses the design of this programme to assess
the performance of a large number of nonexperimental estimators of average treatment
effects, many of which are based on the assumption of unconfoundedness. He sets aside
the original control group from the NSW data and creates several alternative comparison
groups using data from the Current Population Survey (CPS) and the Panel Study of
Income Dynamics (PSID), two standard datasets on the U.S. population. His key insight
is that a ‘good’ estimator should be able to closely replicate the experimental estimate of
the effect of NSW using nonexperimental data. He finds that very few of the estimates
are close to this benchmark. This result motivated a large number of replications and
follow-ups, and established a testbed for estimators of average treatment effects under
unconfoundedness (see, e.g., Heckman and Hotz 1989; Dehejia and Wahba 1999, 2002;
8Recent work by Calo´nico and Smith (2017) highlights the effects of the NSW programme for women.
Prior to this women were largely ignored in the NSW literature subsequent to LaLonde (1986) because the
analysis datafile for women was not preserved.
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Smith and Todd 2001, 2005; Abadie and Imbens 2011; Diamond and Sekhon 2013). Like
many other papers, we use the largest of the six nonexperimental comparison groups
constructed by LaLonde (1986), which he refers to as CPS-1.
4.2 Approach
In this paper we take the key insight of LaLonde (1986) one step further. We treat the
NSW–CPS data from LaLonde (1986) as a finite population, with 185 treated observations
and 7,660 comparison observations in our main example. This comes from taking the
treated sample used by Dehejia and Wahba (1999) and a trimmed version of the CPS-1
dataset, where the literature suggests conditional independence might hold using the
available conditioning variables.9 From this we draw 1,000 samples, each composed of
100 treated observations and 1,900 comparison observations. We then implement the es-
timators described below. For each sample and each estimator we compute the difference
between the estimate and the ‘true effect’ ($1,794), which comes from the experimental
estimate of the impact of NSW on earnings. With 1,000 such differences for each estima-
tor, we can compute the MSE and other performance measures for that estimator in these
data. Then, on each of the 1,000 samples, we implement the two EMCS procedures de-
scribed in Section 2, and compare their performances in terms of the criteria introduced
in Section 3.
One limitation of this approach is that the ‘true effect’ we calculate is subject to sam-
pling error. We therefore consider a second case, where we apply the insight of Smith
and Todd (2005) that the control sample from the NSW can be compared to the same non-
experimental comparison group. The NSW control sample includes people who were
selected in the same way as those actually treated, but who were randomised out of treat-
ment. Now we know that the ‘true effect’ is a precise zero, since the control sample did
not actually receive treatment. Thus, we have an original dataset of 142 ‘treated’ obser-
vations (who in reality received no treatment) and 7,467 comparison units. This comes
from taking the ‘early random assignment’ control sample from Smith and Todd (2005)
and a version of the CPS-1 dataset trimmed to overlap with these controls. Again we
draw samples by selecting 100 treated observations and 1,900 comparison observations
from this population, with the true effect being precisely zero in each sample, and then
perform EMCS on these samples.
9Weuse a logit model to predict propensity to be in the experimental data (either as treatment or control)
versus being in the CPS-1 data. We then drop all CPS-1 observations with propensity scores below the
minimum or above the maximum in the experimental data. This is the trimmed CPS-1 dataset, which we
then combine with the NSW treated observations from Dehejia and Wahba (1999).
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Another possible worry might be that our example applies estimators that are suit-
able under unconfoundedness, i.e. when potential outcomes are independent of treat-
ment assignment, conditional on observed covariates. Smith and Todd (2005) question
this assumption in the context of the NSW–CPS data, and especially in the context of
their ‘early random assignment’ samples. To address this concern, we take a third ap-
proach. The basic idea is to construct a population similar to the NSW–CPS data where
unconfoundedness holds by construction, and then draw samples from this. We begin
with a trimmed version of the Dehejia and Wahba (1999) dataset used in the first case.
Next, we perform 4-nearest neighbour matching (with replacement) to impute the ‘miss-
ing’ potential outcome for each observation. This is our new population, in which we
have complete knowledge of both potential outcomes, as well as a propensity score for
each observation estimated from the NSW–CPS data. We then draw random subsamples
of 2,000 observations (covariates, potential outcomes, and propensity scores) from this
artificially created population. For each observation we create a perturbed propensity
score by adding a logistic error to the NSW–CPS estimated propensity score. We assign
to treatment the individuals in the top quarter of the perturbed propensity score distribu-
tion (giving 500 treated and 1,500 nontreated in each sample). By construction treatment
is therefore ensured to be independent of potential outcomes in this subsample. The
overlap assumption is also satisfied, since the inclusion of a logistic error ensures that no
individual is guaranteed to be treated. The true value of ATT in this sampling process is
given by 1
Pr(D=1)
·E [e(x) · (Y(1) −Y(0))], where e(x) is the probability of being treated in
the assignment rule based on the ranking of the perturbed propensity scores. By design
we know Y(1), Y(0), and Pr(D = 1) = .25, and we can approximate e(x) by the empirical
frequencies in the simulations. Finally, we implement EMCS on the samples drawn in
this way.
4.3 Estimators
In all our simulations we study the impact of the NSW programme on earnings in 1978.
We consider seven nonexperimental estimators: linear regression, Oaxaca–Blinder, in-
verse probability weighting (IPW), doubly-robust regression, uniform kernel matching,
nearest neighbour matching, and bias-adjusted nearest neighbour matching. For details
see Appendix B. In each case we focus on the average treatment effect on the treated
(ATT), unless a given method does not allow for heterogeneity in effects (in which case
we estimate the overall effect of treatment). As noted above, all of these estimators are
based on the assumption of unconfoundedness.
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We use a single set of control variables in all our simulations. Following Dehejia and
Wahba (1999) and Smith and Todd (2005), we control for age, age squared, age cubed,
education, education squared, whether a high school dropout, whether married, whether
black, whether Hispanic, earnings in months 13–24 prior to randomization, earnings in
1975, nonemployment in months 13–24 prior to randomization, nonemployment in 1975,
and the interaction of education and earnings in months 13–24 prior to randomization.
We conduct all our simulations in Stata and use several user-written commands in our
estimation procedures: nnmatch (Abadie et al. 2004), oaxaca (Jann 2008), and psmatch2
(Leuven and Sianesi 2003).
4.4 Procedures
In Section 2 we noted that for the placebo design we require some choice of π and λ,
where λ determines the degree of covariate overlap between the ‘placebo treated’ and
‘placebo control’ observations and π determines the proportion of the ‘placebo treated’.
We choose π to ensure that the proportion of the ‘placebo treated’ observations in each
placebo EMCS replication is equal to the proportion of treated units in the sample.10 We
also follow Huber et al. (2013) in choosing λ = 1 as well as in using a logit model to
estimate the propensity score.
The structured design requires more choices, in particular how we specify the joint
probability distribution as the product of the marginal distribution for treatment status
and some conditional distributions. As discussed in Section 2, we begin each structured
EMCS replication by generating a fixed number of treated and nontreated observations to
match the numbers in the sample. We then order the covariates, regress each covariate on
the preceding covariates (using logistic regression for binary covariates), and use this to
define the conditional distribution for that covariate. In EMCS replications the covariates
are then drawn in the same order, from the appropriate conditional distribution. Full
details of the procedure are provided in Appendix C.
5 Results
We now describe the results of our tests of the two EMCS procedures – placebo and struc-
tured – in the context of our real-world data. As described in Subsection 4.2, we perform
10It should be noted, however, that the way these datasets were constructed by LaLonde (1986) results
in samples that are best described as choice-based. More precisely, the treatment and control groups are
heavily overrepresented relative to their population proportions. See Smith and Todd (2005) for a further
discussion of this issue.
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three sets of tests. First, we apply the two procedures to the NSW treatment sample, com-
bined with the CPS-1 comparison dataset. We find the performance of the procedures
to be poor when it comes to finding the estimator with the lowest bias. When we study
MSE (i.e., account also for variance), performance is better. This is because the rankings
of estimators are mainly being driven by the variance, and both EMCS methods do well
at replicating the variance components. However, given this, we also test a simple boot-
strap procedure and find that it is more effective at picking the best estimator. Then, we
follow Smith and Todd (2005) in using the NSW controls as our ‘treated’ sample instead:
now the effect we intend to estimate must be zero for sure, removing worries that poor
performance might be an artefact caused by sampling uncertainty around the true effect.
We find that the previous results are maintained. Finally, we use an adjusted version of
the original data, constructed so that conditional independence necessarily holds, to allay
concerns that poor performance is driven by a context in which unconfoundedness may
not hold. Again we find that the EMCS procedures do not perform well on bias, and are
better on MSE, although here the bootstrap does not clearly dominate.
5.1 Testing EMCS in the NSW Data
Our first results using ‘real-world’ data focus on the variant of the original NSW treat-
ment sample constructed by Dehejia and Wahba (1999), combined with a trimmed ver-
sion of the CPS-1 comparison dataset. We create 1,000 samples from the original dataset
by sampling 100 treated and 1,900 nontreated observations from the 185 possible treated
and 7,660 comparison units in the original data. We implement the two EMCS proce-
dures 1,000 times on each of the 1,000 samples, giving a total of 1,000,000 replications for
each EMCS procedure. In each replication we implement the seven estimators described
earlier, and measure how well the two EMCS procedures help us assess the relative per-
formance of the estimators. We might measure performance of an estimator in terms of
absolute bias or MSE (which also takes into account its variance). Performance of EMCS
(‘EMCS-validity’) is thenmeasured by howwell the EMCS procedure replicates these fea-
tures of an estimator in the original samples. In Section 3, we described two measures of
EMCS performance suitable for when we have many estimators:
1. the average regret, i.e. average difference in absolute bias/MSE between the es-
timator selected by EMCS and the estimator with the actual minimum absolute
bias/MSE; and
2. the average Kendall’s tau (Kendall’s rank correlation coefficient), which measures
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the similarity between the ranking of estimators suggested by EMCS and the ‘true’
ranking from the original samples.
For ease of interpretation, it is also useful to normalise the values of average regret. Our
discussion below focuses on the average regret as a percentage of the minimum value of
absolute bias/MSE. However, we also consider an alternative normalisation, where we
divide the average regret for a given EMCS procedure by the average regret for random
selection of estimators (which we discuss further below). Finally, we also consider an
additional measure, which is straightforward to interpret, namely
3 the average correlation in absolute bias/MSE (rather than in the rankings, as given
by Kendall’s tau).
In each case the comparison is between what the EMCS procedure suggests and the re-
sults from taking the ‘true effect’ in the original data, and then calculating the absolute
bias/MSE of each estimator across the 1,000 samples.
To provide a benchmark for the performance of EMCS, we also include results from
two other procedures. In the first we simply apply nonparametric bootstrap to the same
samples used for the EMCS procedures.11 We can then compare estimators on absolute
bias, variance, or MSE, and also see how the resulting rankings compare to those from the
original samples. Our estimates of absolute bias and MSE are centred around the point
estimates in each original sample. In the second we do not create any samples, but simply
rank estimators randomly. This provides a ‘worst-case’ benchmark: suppose a researcher
knows nothing at all about performance and just picks an estimator blindly, how would
they do? Here we cannot compute a result for the correlation, but can for average regret
and Kendall’s tau. Table 1 shows the results from these simulations. Appendix F in
Advani et al. (2019) provides further details.
The first result is that performance of both EMCS procedures in terms of bias is very
poor. The average regret in terms of absolute bias, as a percentage of the absolute bias
for the best estimator, is 3,067% (3,766%) for placebo (structured), i.e. an order of mag-
nitude larger than the minimum value. It is worse than choosing completely randomly,
which would be 1,184% worse than the best estimator, and worse than the bootstrap,
1,000%. Looking at the ranking across estimators, the average Kendall’s tau is –.21 (–.37)
for placebo (structured). So the rankings produced by EMCS are, on average, negatively
correlated with the ranking in the original samples. This is worse than random, which
11Precisely, we sample with replacement, and draw replication samples of the same size as the original
sample. In consequence, our bootstrap samples are also of the same size as the structured samples. Both
are larger than the placebo samples, which are of the size of the original comparison subsample.
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Table 1: EMCS-validity using different performance metrics
EMCS approach Placebo Structured Bootstrap Random
Absolute bias (minimum = 16)
Average regret (% of minimum) 3,067 3,766 1,000 1,184
Average regret (% of random) 259.0 318.1 84.5 100.0
Average Kendall’s tau –.214 –.372 .016 0
Average correlation –.437 –.505 .275 —
Mean squared error (minimum = 512,322)
Average regret (% of minimum) 18.2 16.3 7.9 141.9
Average regret (% of random) 12.8 11.5 5.6 100.0
Average Kendall’s tau .599 .635 .828 0
Average correlation .647 .791 .809 —
Variance (minimum = 454,278)
Average regret (% of minimum) 2.7 11.2 1.9 148.0
Average regret (% of random) 1.8 7.6 1.3 100.0
Average Kendall’s tau .767 .812 .883 0
Average correlation .895 .920 .862 —
Notes: ‘EMCS approach’ denotes the way in which the empirical Monte Carlo samples were generated.
‘Placebo’ and ‘Structured’ generate samples using the placebo and structured approaches described in Sec-
tion 2. ‘Bootstrap’ generates nonparametric bootstrap samples by sampling with replacement the same num-
ber of observations as the original data. ‘Random’ does not generate samples but instead randomly assigns
rankings to the estimators (hence statistics are only available for the performance metrics based on rankings).
The absolute bias, mean squared error, and variance are features of estimators. The ‘minimum’ value for
each feature is its lowest value among our estimators in the original data generating process (i.e.we have one
value of each feature for each estimator in the ‘original samples’ and we report the lowest of these values).
See Appendix F in Advani et al. (2019) for more details. Four performance measures are used for each of
these statistics. ‘Average regret’ measures the average increase in the statistic from choosing the estimator
actually selected by the EMCS approach rather than the estimator with the minimum value of this statistic, as
a percentage of (i) that minimum value or (ii) the average regret for random selection of estimators. ‘Average
Kendall’s tau’ measures the average correlation in the ranking of estimators provided by the EMCS approach
relative to the ranking in the original samples. ‘Average correlation’ measures the average correlation in the
actual values of the statistic (rather than the ranking) provided by the EMCS approach relative to the values
in the original samples. All averages are taken with respect to 1,000 original samples; for each sample, a sep-
arate simulation study was conducted. The results for random selection of estimators are analytical; instead
of actually generating random rankings, we report the known values of expected Kendall’s tau (zero) and
expected regret with random rankings. The latter value is equal to the average regret across estimators, with
an equal probability of each estimator to be selected as ‘best’.
gives .00, and bootstrap, .02. The same pattern is seen in the average correlation coeffi-
cients for absolute bias, which are –.44 (–.51).
A researcher might be interested in knowing about performance of estimators in terms
of MSE rather than only considering bias. Here EMCS performs much better. The average
regret for placebo (structured) is now only 18% (16%), much better than random (142%).
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Similarly, average Kendall’s tau is now .60 and .64 for placebo and structured, respec-
tively, much better than .00 for random. The lowest panel of Table 1 shows that this is
driven by the much better performance in replicating the variances. Since the rankings
here are mostly determined by the variance, being able to reproduce variances substan-
tially improves the measures of performance relative to the metrics based on absolute
bias.
However, looking at our other benchmark case – the bootstrap – we see that it out-
performs both EMCS methods in terms of MSE. Average regret is lower at 7.9%, and the
average Kendall’s tau is much higher at .83. Given that MSE performance for EMCS is
driven by the variance components, this does not seem surprising. The bootstrap is a
simpler procedure than the two EMCS methods, and its ability to help us understand the
variability of estimators is well known. It therefore seems like a potentially valuable path
which has fewer design choices than EMCS.
5.2 Removing Sampling Error from the ‘True Effect’
The previous subsection calculated the MSE for each estimator by comparing the value of
the estimate in each sample to a ‘true effect’ measured using the experiment. One concern
might be that the estimate from the experiment is subject to sampling error, and this might
somehow negatively affect our performance measures for EMCS. To test this, we now use
as our ‘treated’ observations the ‘early random assignment’ NSW control sample from
Smith and Todd (2005). Since these individuals were selected for the programme in the
same way as those actually treated, but were then randomised out, the actual treatment
effect for them is precisely zero. We therefore repeat the exercise on these data, again
implementing the two EMCS procedures 1,000 times on each of the 1,000 original samples.
Table 2 documents the results. Appendix F in Advani et al. (2019) provides further details.
Our conclusions are similar to those in the previous subsection. In terms of abso-
lute bias, the average regret is much lower than previously, at 30% (42%) for placebo
(structured). However, this is mostly driven by a large increase in the minimum value
of absolute bias, since it is much more difficult to recover the true effect of NSW in these
data (Smith and Todd, 2005). This can alternatively be seen from normalising values by
the average regret for random selection of estimators. In the first simulation study, the
average regret for placebo (structured) is 2.6 (3.2) times larger than for random; in the
second, it is 1.6 (2.2) times larger. While these values continue to be smaller in the second
simulation study, their overall magnitudes are similar in both cases. This also makes it
clear that EMCS is still worse than choosing at random (average regret of 19%) and boot-
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Table 2: EMCS-validity ensuring no sampling error in the treatment effect
EMCS approach Placebo Structured Bootstrap Random
Absolute bias (minimum = 954)
Average regret (% of minimum) 30.2 41.6 10.4 19.0
Average regret (% of random) 158.9 219.1 54.9 100.0
Average Kendall’s tau –.274 –.466 .320 0
Average correlation –.418 –.822 .263 —
Mean squared error (minimum = 1,222,627)
Average regret (% of minimum) 22.5 32.1 17.4 94.4
Average regret (% of random) 23.9 34.0 18.4 100.0
Average Kendall’s tau .645 .549 .809 0
Average correlation .843 .814 .746 —
Variance (minimum = 296,671)
Average regret (% of minimum) 1.2 5.0 9.0 262.6
Average regret (% of random) .5 1.9 3.4 100.0
Average Kendall’s tau .950 .665 .762 0
Average correlation .959 .934 .833 —
Notes: See Table 1.
strap (10%). As before, the average Kendall’s tau is negative for placebo (structured) at
–.27 (–.47), which is worse than random (.00) and bootstrap (.32) as well. On MSE perfor-
mance is better, with average regret of 23% (32%) and average Kendall’s tau of .65 (.55).
These are much better than random (94% and .00), but worse than bootstrap (17% and
.81).
5.3 Ensuring Unconfoundedness Holds
Another potential concern is whether the conditional independence assumption holds.
Here we take the approach described in Subsection 4.2 to generate 1,000 samples in which
conditional independence holds by construction. Then, we implement the two EMCS
procedures 500 times on each of these samples. Table 3 displays the results. Appendix F
in Advani et al. (2019) provides further details.
The previous results are broadly maintained even after ensuring conditional indepen-
dence. In terms of absolute bias the performance of both EMCS approaches is similar to
random, though now slightly better than bootstrap. In terms of MSE both procedures
perform better than random selection of estimators and also marginally better than boot-
strap. Average regret in terms of MSE is worse than in the first case, though average
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Table 3: EMCS-validity ensuring unconfoundedness holds
EMCS approach Placebo Structured Bootstrap Random
Absolute bias (minimum = 68)
Average regret (% of minimum) 593.5 670.1 972.1 522.0
Average regret (% of random) 113.7 128.4 186.2 100.0
Average Kendall’s tau –.003 .057 –.300 0
Average correlation –.048 .217 –.263 —
Mean squared error (minimum = 340,300)
Average regret (% of minimum) 260.1 89.7 276.1 682.9
Average regret (% of random) 38.1 13.1 40.4 100.0
Average Kendall’s tau .737 .729 .632 0
Average correlation .943 .790 .778 —
Variance (minimum = 137,574)
Average regret (% of minimum) 0 .3 0 1,631
Average regret (% of random) 0 0 0 100.0
Average Kendall’s tau .768 .727 .752 0
Average correlation .951 .820 .820 —
Notes: See Table 1.
Kendall’s tau is a little higher, so it is also not obvious that contexts where conditional
independence holds should necessarily see better performance of EMCS procedures.
6 Discussion
Advances in econometrics have left the empirical researcher blessed with a wealth of pos-
sible treatment effect estimators from which to choose. They have not yet provided clear
guidance on which of these estimators should be preferred in which context. In this paper
we studied two proposals which suggest an approach to choosing an appropriate estima-
tor for a given context. The first approach (placebo) suggests a way to introduce placebo
treatments to some control observations in a dataset, and studies howwell estimators can
pick up the true zero effect. The second approach (structured) creates data from a known
DGP whose parameters are estimated from features of the original data, and studies how
well estimators can pick up the implied true effect in the DGP.
We showed theoretically that both approaches can only be guaranteed to work under
rather restrictive conditions. Specifically, when they can correctly reproduce both the bi-
ases and the ordering of the variances of estimators. We showed simple practical cases
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where one or other of these might fail, and gave an example of the consequences based
on simulations from an artificial DGP. To provide a real-world example, we also imple-
mented the EMCS procedures in the NSW–CPS data, where we know the ‘true effect’ of
the programme. This allowed us to compute actual performance of the estimators in sam-
ples from the original data, and compare this to what EMCS would suggest if applied to
these samples. We showed that in this example EMCS performs badly on ordering esti-
mators in terms of absolute bias, and the estimator it suggests is often many times worse
than the best (or even than selecting randomly). In this example both EMCS procedures
perform much better in terms of MSE because reproducing the variance term turns out to
drive the MSE in these data. But, this leads the methods to be no better (and sometimes
substantially worse) than a simple bootstrap procedure.
These results are unfortunate, but nevertheless important. There remains no silver
bullet that can assist empirical researchers with the ‘right’ or ‘best’ estimator for a partic-
ular context. In the absence of a clear choice driven by research design, the best advice at
this stage is likely to be implementing a number of estimators, and then considering the
range of estimates provided, as Busso et al. (2014) also suggest.
One possible future alternative, recently proposed, is synth-validation (Schuler et al.,
2017). This approach is related to cross-validation and is based on estimating ‘the esti-
mation error of causal inference methods applied to a given dataset’. The authors pro-
vide simulations which suggest that this ‘lowers the expected estimation error relative to
consistently using any single method’. Further work is needed to test how general this
approach is, and whether it can reliably guide researchers in selecting estimators.
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Appendix
A Theory
Derivations of (8) and (9): A general expression of SEB for ATT in the absence of knowl-
edge of the propensity score is given by
SEBATT =
1
Pr(D = 1)
E
[
Var(Y(1)|X) + e(X)
1− e(X)Var(Y(0)|X) + (τ(X) − θ
0)2|D = 1
]
.
Plugging the current specifications for Var(Y(1)|X) and Var(Y(0)|X) and noting τ(X) =
θ0 for all X, the expression of (8) follows.
By the partialling out argument of the least squares regression and the linear proba-
bility specification of the propensity score, the asymptotic variance of
√
n(θˆ2 − θ0) can be
written as
Avar(
√
n(θˆ2 − θ0)) = E(ǫ
2(D− e(X))2)
[E((D − e(X))2)]2
=
E
[
Var(Y(1)|X)(1 − e(X))2e(X) +Var(Y(0)|X)e(X)2(1− e(X))]
[E(e(X)(1 − e(X))]2
=
σ2
Pr(D = 1)
· E
[
c(1− e(X))2 + e(X)(1− e(X))|D = 1]
[E(1− e(X)|D = 1)]2 ,
where the third line follows from Bayes rule applied to each denominator and numerator.

Proof of (10): Rewrite (8) and (9) as
σ21 =
σ2
Pr(D = 1)
[
c− 1+ E
(
1
1− e(X) |D = 1
)]
, (13)
σ22 =
σ2
Pr(D = 1)
[
(c− 1) · E((1− e(X))
2 |D = 1)
[E(1− e(X)|D = 1)]2 +
1
E(1− e(X)|D = 1)
]
. (14)
Hence, we obtain
σ22 − σ21 =
σ2
Pr(D = 1)
[(c− 1)∆2 − ∆1] , (15)
∆1 ≥ 0 by Jensen’s inequality, and ∆2 ≥ 0. Hence, the condition for σ22 > σ21 follows as in
(10). 
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B Empirical Application: Estimators
We use seven estimators in our empirical application.
1. Linear regression (OLS).
2. Oaxaca–Blinder – we follow Kline (2011) in using the Oaxaca–Blinder decomposi-
tion to estimate the ATT.
3. Inverse probability weighting (IPW) – we first estimate the propensity score using
a logit model, and then use inverse weighting with normalised weights to estimate
the ATT.
4. Doubly-robust regression – as inWooldridge (2007) and Słoczyn´ski andWooldridge
(2018), we use the inverse-probability-weighted regression-adjustment (IPWRA) es-
timator. This is effectively a combination of the two estimators above, IPW and
Oaxaca–Blinder. It satisfies the double robustness property.
5. Uniform kernel matching – we first estimate the propensity score using a logit
model, and then match on propensity scores using a uniform kernel. We select the
bandwidth on the basis of leave-one-out cross-validation (as in Busso et al. 2009 and
Huber et al. 2013), using a search grid .005× 1.25g−1 for g = 1, 2, . . . , 15. The com-
putational time of doing this for each replication is prohibitive. Consequently we
calculate this once for each original sample, and use the recovered optimal band-
width in all EMCS replications for that sample.
6. Nearest neighbour matching – nearest neighbour matching on propensity scores,
which are first estimated from a logit regression, withmatching on the single nearest
neighbour. We match with replacement; if there are ties, all of the tied observations
are used.
7. Bias-adjusted nearest neighbourmatching – as above, but correcting bias as in Abadie
and Imbens (2011), since nearest neighbour matching is not
√
n-consistent.
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C Empirical Application: Structured EMCS Procedure
Herewe detail precisely the procedure followed to implement the structured EMCS in our
empirical application. As noted previously, we begin each structured EMCS replication
by generating a fixed number of treated and nontreated observations tomatch the number
in the sample. We then draw an employment status pair of u74 and u75 (nonemployment
in months 13–24 prior to randomization and nonemployment in 1975), conditional on
treatment status, to match the observed conditional joint probability. For individuals
who are employed in only one period, an income is drawn from a log normal distribution
conditional on treatment and employment statuses, with mean and variance calibrated to
the respective conditional moments in the data. Where individuals are employed in both
periods a joint log normal distribution is used, again conditioning on treatment status. In
all cases, whenever the income draw in a particular year lies outside the relevant support
observed in the data, conditional on treatment status, the observation is replaced with the
limit point of the empirical support, as also suggested by Busso et al. (2014).
We model the joint distribution of the remaining control variables as a particular tree-
structured conditional probability distribution, so that we can better fit the correlation
structure in the data. The process for generating these covariates is as follows:
1. The covariates are ordered: treatment status, employment statuses, income in each
period, whether a high school dropout (nodegree), education (educ), age, whether
married, whether black, and whether Hispanic. This ordering is arbitrary, and a
similar correlation structure would be generated if the ordering were changed.
2. Using the sample on which the EMCS is being performed, each covariate from
nodegree onward is regressed on all the covariates listed before it (we use the logit
model for binary variables).12 These regressions are not to be interpreted causally;
they simply give the conditional mean of each variable given all preceding covari-
ates.
3. In the simulated dataset, covariates are drawn sequentially in the same order. For
binary covariates a temporary value is drawn from a U [0, 1] distribution. Then the
covariate is equal to one if the temporary value is less than the conditional probabil-
ity for that observation. The conditional probability is found using the values of the
existing generated covariates and the estimated coefficients from step 2. Age and
12One exception is educ which is regressed on the prior listed covariates conditional on nodegree.
Clearly, it is not possible for a high school dropout to have twelve years of schooling or more; it is also
not possible for a non-dropout to have less than twelve years of schooling.
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education are drawn from a normal distribution whose mean depends on the other
covariates and whose variance is equal to that of the residuals from the relevant
model. Again, we replace extreme values with the limit of the support, conditional
on treatment status (for education, also conditional on dropout status).
The outcome studied is earnings in 1978, re78. The simulated outcome, Yi for individual
i, is then generated in two steps. In the first step, we generate a conditional mean using
the parameters of a flexible linear model fitted to the sampled data. Precisely, we estimate
(δ0, δ1) from the following linear model:
E(Y|D,X) = (1− D)Xδ0 + DXδ1. (16)
The predicted conditional mean in the replication is then calculated using the estimated
coefficients (δˆ0, δˆ1) from above, and the simulated treatment status and covariates, Di
and Xi. In the second step, the simulated outcome, Yi, is determined as a draw from a
normal distribution with the estimated conditional mean (1− Di)Xiδˆ0 + DiXiδˆ1 and the
variance that is fitted to that of the residuals from the model in equation (16), conditional
on treatment status. Once again, we replace extreme values of re78with the limit point of
the support, also conditional on treatment status. ‘True effects’ in each replication, θ˜0, are
calculated using the conditional means for both treatment statuses, and the difference in
conditional means, i.e. the individual-level treatment effect, is averaged over the subsam-
ple of treated units. Thus, we implicitly focus on the sample average treatment effect on
the treated (SATT), not on the population average treatment effect on the treated (ATT).
Both of these measures can be used as the benchmark effect in simulations and we have
no particular preference for either.
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